key: cord-0700746-ldgdukrh authors: Castano‐Jaramillo, Lina Maria; Yamazaki‐Nakashimada, Marco Antonio; Scheffler Mendoza, Selma Cecilia; Bustamante‐Ogando, Juan Carlos; Espinosa‐Padilla, Sara Elva; Lugo Reyes, Saul O. title: A male infant with COVID‐19 in the context of ARPC1B deficiency date: 2020-07-19 journal: Pediatr Allergy Immunol DOI: 10.1111/pai.13322 sha: 6813a5e48bc6f36e08e6ba9c26a387ec463e473e doc_id: 700746 cord_uid: ldgdukrh The current pandemic of the novel SARS‐CoV‐2 infection has affected over 10 million humans around the planet. The clinical manifestations of Coronavirus disease 2019 (COVID‐19) are diverse, ranging from asymptomatic or mild flu‐like symptoms to atypical pneumonia, severe respiratory distress syndrome, systemic inflammation, immune dysregulation and coagulopathy. are diverse, ranging from asymptomatic or mild flu-like symptoms to atypical pneumonia, severe respiratory distress syndrome, systemic inflammation, immune dysregulation and coagulopathy. Inborn errors of immunity (IEI) are a heterogenous group of more than 430 rare congenital disorders with increased susceptibility to infection, autoimmunity, atopy, hyperinflammation and cancer. Autosomal recessive ARPC1B deficiency is an actinopathy, as are DOCK8 deficiency and the Wiskott-Aldrich Syndrome. Defective actin polymerization affects hematopoietic cells, impairing their migration and immunological synapse 1 , which results in a combined immune deficiency characterized by leukocytosis, eosinophilia, platelet abnormalities and hypergammaglobulinemia; and clinically, by eczema and food allergy, infections caused by bacteria, fungi and viruses, vasculitis, and bleeding diathesis 2 . Here, we describe a male infant patient with known ARPC1B deficiency, who was hospitalized for COVID-19 pneumonia and improved without requiring intensive care or mechanical ventilation. Informed consent through protocols approved by the institutional review boards of the National Institute of Pediatrics were obtained from the patient's family. This article is protected by copyright. All rights reserved An 8-month-old male infant was brought to the emergency department with high-grade fever. His family history is remarkable for one brother who died as a newborn from intracranial bleeding, and an 11-year-old sister with the same genetic defect and decreased proliferative response to mitogens, who underwent hematopoietic stem-cell transplantation twice without success, and is currently on antimycobacterial treatment, antimicrobial prophylaxis, and regular subcutaneous immunoglobulin. The patient was first seen at age 1-month old for eczema and rectal bleeding attributed to cow milk protein allergy. At age 4 months, he developed bronchiolitis caused by respiratory syncytial virus (RSV), and oral candidiasis. Laboratory workup revealed leukocytosis (17,500-33,600/mm3), eosinophilia (5,600-20,100/mm3) and a marginally high platelet count (467,000) with normal platelet volume; as well as high serum IgG Upon his arrival to the emergency department, he was febrile with tachycardia and signs of septic shock, requiring rapid fluid resuscitation. He showed no respiratory or gastrointestinal signs, although he also had a post-traumatic ulcerated lesion under the tongue with dark discoloration, which raised a concern for fungal infection. Intravenous antibiotics (ciprofloxacin) with antifungal coverage were started within the first hour, and a dose of intravenous immunoglobulin (IVIG) at 1g/kg. Blood counts revealed leukocytosis, neutrophilia, and mild eosinophilia without lymphopenia, while platelets were initially found within normal limits. A day later, blood culture had grown Pseudomonas aeruginosa. During his second day of hospitalization, the patient persisted febrile, tachycardic and tachypneic, with oxygen desaturation into the low 80s. Chest X-ray showed nonspecific bilateral interstitial opacities in the perihilar regions (Figure 1 ). Real-time Polymerase chain reaction (RT-PCR) for SARS-CoV-2, an oral swab taken upon admission, came back positive and he was then transferred to a COVID-19 isolation area. There was no known contact with another positive COVID-19 case. This article is protected by copyright. All rights reserved The potassium hydroxide (KOH) test for oral thrush was negative for yeast cells, after which amphotericin was switched to fluconazole. Supplemental oxygen was discontinued on day 6 of hospitalization, when mild thrombocytopenia and a prolonged thromboplastin time (aPTT) (but normal fibrinogen and ferritin serum levels) were reported. See Table 1 This article is protected by copyright. All rights reserved Conceivably, some immune defects could protect patients with certain IEIs from mounting a full uncontrolled inflammatory response against SARS-CoV-2 9 . The cytoskeleton is a regulator of gene transcription, coupling cell mechanics with the activity of NF-B. RNA betacoronaviruses are thought to alter the cytoskeleton architecture to facilitate viral replication and output 10 . Thus, ARPC1B deficiency and other actinopathies might limit SARS-CoV-2 replication. Furthermore, Th2 cytokines modulate ACE2 (angiotensin-converting enzyme 2) and TMPRSS2 expression in airway epithelial cells 11 , and children with allergies (asthma and/or allergic rhinitis) have a lower expression of ACE2 12 . Patients with ARPC1B deficiency often have allergic diseases; their Th2-biased response could help explain the milder presentation seen in our patient. Insights from protective mechanisms in children, with and without certain immune defects, could facilitate the identification of therapeutic targets. Loss of ARPC1B impairs cytotoxic T lymphocyte maintenance and cytolytic activity Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019 Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Eigenmann P, ed. Pediatric Allergy and Immunology A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza Positive Outcome in a COVID-19 patient with Common Variable Immunodeficiency after IVIG Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Clinics (Sao Paulo, Brazil) The first, holistic immunological model of COVID-19 This article is protected by copyright. All rights reserved